Crescent Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:CBIO

Comments

Crescent Biopharma Inc Earnings Estimates

CBIONASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$9.51

0.11.06%

At close: Feb 6, 4:00 PM EST

$9.51

N/A

After Hours: Feb 6, 4:00 PM EST

Overview News

Earnings

Analyst Ratings Insider Trades Short Interest Stock Report

Crescent Biopharma Earnings Estimates, EPS & Revenue | NASDAQ:CBIO | Benzinga

Crescent Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Feb 23

EPS Estimate

$-2.510

Quarterly Revenue Estimate

$12.50M

Annual Revenue
(as of Dec 31)

–

Analyze the earnings history of Crescent Biopharma using advanced sorting and filters.

Crescent Biopharma (CBIO) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %

Q3	2025-11-06	$-1.27	$-1.23	-3.25 %
Q2	2025-07-31	$-4.93	$-1.08	-356.5 %

Crescent Biopharma (CBIO) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %

FAQ

When is Crescent Biopharma (NASDAQ:CBIO) reporting earnings?

Crescent Biopharma (CBIO) is scheduled to report earnings on February 23, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.

What were the latest earnings per share (EPS) for Crescent Biopharma (NASDAQ:CBIO)?

The Actual EPS was $-1.27, which missed the estimate of $-1.23.

What were Crescent Biopharma’s (NASDAQ:CBIO) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch

Burning Rock Biotech Ltd

Larimar Therapeutics Inc

Armata Pharmaceuticals Inc

Enlivex Therapeutics Ltd

NASDAQ:ENLV

$1.15

-0.86%